Mechanisms of Contraction of the Normal and Failing Heart. 70(1):68-79.īraunwald E, Ross J Jr, Sonnenblick EH. The pathogenesis of congestive heart failure: then and now.

FDA approves heart sympathetic activity imaging agent for HF evaluation. HFSA 2010 comprehensive heart failure practice guideline. Lindenfeld J, Albert NM, Boehmer JP, et al, for the Heart Failure Society of America. Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Ponikowski P, Voors AA, Anker SD, et al, for the Authors/Task Force Members. Key points from the new heart failure guidelines. New HF guidelines feature 'quad' therapy, tweaked terminology. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: executive summary: s report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Yancy CW, Jessup M, Bozkurt B, et al, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 22(4 suppl A):6A-13A.Īmerican Heart Association. The epidemiology of heart failure: the Framingham Study. Angiotensin Receptor-Neprilysin Inhibitors (ARNi).Management of Acute Decompensated Heart Failure (ADHF).Treatment of Right Ventricular Heart Failure.Treatment of Heart Failure with Preserved LVEF.Heart Failure Criteria, Classification, and Staging.

Medical term ivcd